Results of a phase II multicenter study of obinutuzumab plus bendamustine in pts with previously untreated chronic lymphocytic leukemia

Category Primary study
JournalHaematologica
Year 2017
This article has no abstract
Epistemonikos ID: 03c63f9aaa1bc276abefdbbd0db6a1da5d48a034
First added on: Feb 08, 2025